NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹260 Cr | ₹300 Cr | ₹164 Cr | ₹64 Cr | ₹81 Cr |
What is the latest Consolidated Net Profit of NEULAND LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹260 Cr |
| Mar2024 | ₹300 Cr |
| Mar2023 | ₹164 Cr |
| Mar2022 | ₹64 Cr |
| Mar2021 | ₹81 Cr |
How is Consolidated Net Profit of NEULAND LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹260 Cr | -13.32 | |
| Mar2024 | ₹300 Cr | 83.51 | |
| Mar2023 | ₹164 Cr | 156.21 | |
| Mar2022 | ₹64 Cr | -20.85 | |
| Mar2021 | ₹81 Cr | - | |
Compare Consolidated Net Profit of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹16,067.5 Cr | -7.8% | -16% | -7.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -7.8% |
-16% |
-7.4% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses